PARSIPPANY, N.J., June 21 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that Dr. Anthony Coles, president and CEO, will present a company update at the Jefferies Life Sciences Conference in New York, NY at 1:45 p.m. EDT on Wednesday, June 28, 2006. The live event webcast may be accessed on the NPS site, www.npsp.com. A replay will be available approximately three hours after the presentation has concluded and may be accessed at the same link.

About NPS Pharmaceuticals

NPS discovers and develops small molecule and recombinant protein drugs, primarily for the treatment of metabolic, bone and mineral, and central nervous system disorders. The company has two products on the market, cinacalcet HCl in the US and Europe, and PREOTACT(R) in Europe. The company also has drug candidates in various stages of clinical development backed by a strong discovery research effort. Additional information is available on the company's website, http://www.npsp.com.

SOURCE NPS Pharmaceuticals, Inc.